Boston Therapeutics, Inc. Purchase Agreements
12 Contracts & Agreements
- Securities Purchase Agreement, dated March 23, 2022 (Filed With SEC on March 24, 2022)
- Securities Purchase Agreement, dated February 28, 2022 (Filed With SEC on March 1, 2022)
- Securities Purchase Agreement, dated June 25, 2021, by and between Boston Therapeutics, Inc. and the buyers signatory thereto (Filed With SEC on June 29, 2021)
- Form of Securities Purchase Agreement entered between Boston Therapeutics, Inc. dated August 14, 2017 (Filed With SEC on August 22, 2017)
- Securities Purchase Agreement entered between Boston Therapeutics, Inc. and CJY Holdings Limited (Filed With SEC on May 2, 2017)
- Form of Securities Purchase Agreement entered with the August 2016 Accredited Investors (Filed With SEC on August 15, 2016)
- Form of Securities Purchase Agreement by and between Boston Therapeutics, Inc. and CJY Holdings Limited (Filed With SEC on October 2, 2015)
- Securities Purchase Agreement between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC dated as of March 12, 2015 (Filed With SEC on May 20, 2015)
- Securities Purchase Agreement between Boston Therapeutics, Inc. and Vis Vires Group, Inc. dated as of March 16, 2015 (Filed With SEC on May 20, 2015)
- Securities Purchase Agreement between Boston Therapeutics, Inc. and JDF Capital, Inc. dated as of March 13, 2015 (Filed With SEC on May 20, 2015)
- Unit Purchase Agreement between Boston Therapeutics, Inc. and the investors named therein dated as of July 23, 2013, as amended (Filed With SEC on November 14, 2013)
- Unit Purchase Agreement between Boston Therapeutics, Inc. and the investors named therein dated as of July 23, 2013, as amended (Filed With SEC on November 13, 2013)
